4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-045387
EVP and General Counsel sold 3,750 shares at an average $8.62 ($32,332)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| de Verneuil Vanina EVP and General Counsel | 2024-11-01 | Sale 10b5-1 | −1,403 | $7.20 | $10,107 | 63,717 | D |
| de Verneuil Vanina EVP and General Counsel | 2024-11-05 | Sale 10b5-1 | −2,347 | $9.47 | $22,225 | 61,370 | D |
| Open-market sales · 3,750 sh · avg $8.62 · $32,332 | |||||||
Loading xslF345X05/wk-form4_1730847101.xml…